Akebia Therapeutics
AKBA
AKBA
145 hedge funds and large institutions have $423M invested in Akebia Therapeutics in 2018 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 57 increasing their positions, 39 reducing their positions, and 28 closing their positions.
Holders
145
Holders Change
-8
Holders Change %
-5.23%
% of All Funds
3.32%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.07%
New
20
Increased
57
Reduced
39
Closed
28
Calls
$9M
Puts
$662K
Net Calls
+$8.34M
Net Calls Change
+$5.32M
Top Buyers
1 |
NCM
1
Nantahala Capital Management
New Canaan,
Connecticut
|
$45.1M |
2 |
2
BlackRock
New York
|
$50.1M |
3 |
3
State Street
Boston,
Massachusetts
|
$19.3M |
4 |
4
Citadel Advisors
Miami,
Florida
|
$6.19M |
5 |
![]()
5
Marshall Wace
London,
United Kingdom
|
$5.38M |